CAMP4 Net Working Capital vs Net Debt Analysis

CAMP Stock

USD 1.65 0.02 1.23%

CAMP4 THERAPEUTICS financial indicator trend analysis is way more than just evaluating CAMP4 THERAPEUTICS prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CAMP4 THERAPEUTICS is a good investment. Please check the relationship between CAMP4 THERAPEUTICS Net Working Capital and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Net Working Capital vs Net Debt

Net Working Capital vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CAMP4 THERAPEUTICS Net Working Capital account and Net Debt. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between CAMP4 THERAPEUTICS's Net Working Capital and Net Debt is 0.41. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Net Debt in the same time period over historical financial statements of CAMP4 THERAPEUTICS PORATION, assuming nothing else is changed. The correlation between historical values of CAMP4 THERAPEUTICS's Net Working Capital and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of CAMP4 THERAPEUTICS PORATION are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Net Working Capital i.e., CAMP4 THERAPEUTICS's Net Working Capital and Net Debt go up and down completely randomly.

Correlation Coefficient

0.41

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Net Working Capital

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from CAMP4 THERAPEUTICS's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CAMP4 THERAPEUTICS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

As of 08/03/2025, Sales General And Administrative To Revenue is likely to grow to 24.03, while Selling General Administrative is likely to drop slightly above 14.2 M.

	2022	2023	2024	2025 (projected)
Total Revenue	294.9M	186.2M	652K	619.4K
Depreciation And Amortization	21.8M	1.7M	2.0M	1.9M

Total Revenue Depreciation And Amortization

CAMP4 THERAPEUTICS fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Good Will	Intangible Assets	Current Deferred Revenue
Total Assets		0.93	-0.6	0.91	0.66	0.68	0.62	0.37	0.82	0.93	0.7	0.77	0.94	0.61	0.85	0.71	0.76	0.4	0.9	0.94	0.5	0.88	0.69	0.47	0.68	0.86
Short Long Term Debt Total	0.93		-0.56	0.9	0.39	0.8	0.81	0.17	0.71	0.92	0.87	0.64	0.88	0.47	0.94	0.63	0.88	0.28	0.97	0.83	0.47	0.85	0.55	0.6	0.58	0.89
Other Current Liab	-0.6	-0.56		-0.45	-0.46	-0.13	-0.32	-0.34	-0.56	-0.43	-0.39	-0.58	-0.66	-0.49	-0.49	-0.27	-0.43	-0.21	-0.5	-0.67	0.03	-0.72	-0.58	-0.01	-0.18	-0.4
Total Current Liabilities	0.91	0.9	-0.45		0.46	0.84	0.84	0.19	0.52	0.98	0.86	0.45	0.95	0.57	0.81	0.64	0.9	0.34	0.89	0.73	0.51	0.91	0.73	0.51	0.6	0.97
Total Stockholder Equity	0.66	0.39	-0.46	0.46		0.11	0.0	0.58	0.65	0.48	0.08	0.68	0.59	0.34	0.18	0.39	0.19	0.62	0.26	0.74	0.32	0.49	0.64	-0.11	0.45	0.38
Property Plant And Equipment Net	0.68	0.8	-0.13	0.84	0.11		0.85	-0.15	0.33	0.83	0.89	0.22	0.66	0.33	0.75	0.56	0.85	0.26	0.81	0.47	0.63	0.61	0.35	0.71	0.48	0.9
Net Debt	0.62	0.81	-0.32	0.84	0.0	0.85		-0.09	0.17	0.81	0.94	0.1	0.74	0.33	0.74	0.34	0.9	0.07	0.8	0.38	0.32	0.77	0.5	0.53	0.34	0.84
Retained Earnings	0.37	0.17	-0.34	0.19	0.58	-0.15	-0.09		0.41	0.21	-0.18	0.46	0.35	0.06	0.1	0.04	-0.07	-0.28	0.13	0.44	0.26	0.25	0.47	-0.43	0.12	0.11
Cash	0.82	0.71	-0.56	0.52	0.65	0.33	0.17	0.41		0.58	0.33	0.97	0.61	0.4	0.69	0.65	0.41	0.36	0.67	0.93	0.41	0.53	0.35	0.37	0.56	0.51
Non Current Assets Total	0.93	0.92	-0.43	0.98	0.48	0.83	0.81	0.21	0.58		0.84	0.49	0.94	0.57	0.84	0.68	0.87	0.34	0.91	0.75	0.52	0.88	0.68	0.57	0.7	0.95
Non Currrent Assets Other	0.7	0.87	-0.39	0.86	0.08	0.89	0.94	-0.18	0.33	0.84		0.23	0.76	0.39	0.81	0.44	0.96	0.25	0.85	0.5	0.28	0.8	0.47	0.64	0.38	0.9
Cash And Short Term Investments	0.77	0.64	-0.58	0.45	0.68	0.22	0.1	0.46	0.97	0.49	0.23		0.57	0.42	0.61	0.55	0.29	0.35	0.59	0.93	0.36	0.49	0.37	0.23	0.46	0.41
Net Receivables	0.94	0.88	-0.66	0.95	0.59	0.66	0.74	0.35	0.61	0.94	0.76	0.57		0.66	0.78	0.61	0.81	0.34	0.86	0.82	0.38	0.97	0.81	0.37	0.61	0.88
Common Stock Shares Outstanding	0.61	0.47	-0.49	0.57	0.34	0.33	0.33	0.06	0.4	0.57	0.39	0.42	0.66		0.55	0.54	0.43	0.32	0.58	0.57	0.12	0.64	0.63	0.25	0.45	0.52
Non Current Liabilities Total	0.85	0.94	-0.49	0.81	0.18	0.75	0.74	0.1	0.69	0.84	0.81	0.61	0.78	0.55		0.67	0.8	0.09	0.99	0.76	0.41	0.76	0.4	0.69	0.59	0.8
Inventory	0.71	0.63	-0.27	0.64	0.39	0.56	0.34	0.04	0.65	0.68	0.44	0.55	0.61	0.54	0.67		0.46	0.4	0.69	0.65	0.59	0.52	0.22	0.75	0.83	0.57
Other Current Assets	0.76	0.88	-0.43	0.9	0.19	0.85	0.9	-0.07	0.41	0.87	0.96	0.29	0.81	0.43	0.8	0.46		0.27	0.86	0.57	0.31	0.83	0.59	0.55	0.39	0.95
Other Stockholder Equity	0.4	0.28	-0.21	0.34	0.62	0.26	0.07	-0.28	0.36	0.34	0.25	0.35	0.34	0.32	0.09	0.4	0.27		0.16	0.44	0.13	0.32	0.28	0.27	0.41	0.33
Total Liab	0.9	0.97	-0.5	0.89	0.26	0.81	0.8	0.13	0.67	0.91	0.85	0.59	0.86	0.58	0.99	0.69	0.86	0.16		0.78	0.46	0.83	0.5	0.67	0.62	0.88
Total Current Assets	0.94	0.83	-0.67	0.73	0.74	0.47	0.38	0.44	0.93	0.75	0.5	0.93	0.82	0.57	0.76	0.65	0.57	0.44	0.78		0.43	0.76	0.59	0.34	0.6	0.68
Short Term Debt	0.5	0.47	0.03	0.51	0.32	0.63	0.32	0.26	0.41	0.52	0.28	0.36	0.38	0.12	0.41	0.59	0.31	0.13	0.46	0.43		0.2	0.16	0.38	0.46	0.5
Accounts Payable	0.88	0.85	-0.72	0.91	0.49	0.61	0.77	0.25	0.53	0.88	0.8	0.49	0.97	0.64	0.76	0.52	0.83	0.32	0.83	0.76	0.2		0.8	0.35	0.5	0.84
Common Stock	0.69	0.55	-0.58	0.73	0.64	0.35	0.5	0.47	0.35	0.68	0.47	0.37	0.81	0.63	0.4	0.22	0.59	0.28	0.5	0.59	0.16	0.8		-0.15	0.2	0.67
Good Will	0.47	0.6	-0.01	0.51	-0.11	0.71	0.53	-0.43	0.37	0.57	0.64	0.23	0.37	0.25	0.69	0.75	0.55	0.27	0.67	0.34	0.38	0.35	-0.15		0.67	0.52
Intangible Assets	0.68	0.58	-0.18	0.6	0.45	0.48	0.34	0.12	0.56	0.7	0.38	0.46	0.61	0.45	0.59	0.83	0.39	0.41	0.62	0.6	0.46	0.5	0.2	0.67		0.51
Current Deferred Revenue	0.86	0.89	-0.4	0.97	0.38	0.9	0.84	0.11	0.51	0.95	0.9	0.41	0.88	0.52	0.8	0.57	0.95	0.33	0.88	0.68	0.5	0.84	0.67	0.52	0.51

Click cells to compare fundamentals

CAMP4 THERAPEUTICS Account Relationship Matchups

CAMP4 THERAPEUTICS fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	433.8M	391.6M	380.1M	54.9M	78.3M	74.4M
Short Long Term Debt Total	203.5M	205.7M	240.4M	11.7M	8.6M	8.2M
Other Current Liab	(1.5M)	(1.9M)	(25.1M)	3.7M	1.7M	1.8M
Total Current Liabilities	107.2M	90.5M	106.5M	7.8M	9.6M	9.1M
Total Stockholder Equity	95.1M	75.4M	14.3M	(123.7M)	63.1M	66.6M
Property Plant And Equipment Net	55.4M	50.0M	45.1M	13.3M	10.3M	13.2M
Net Debt	108.9M	126.4M	198.5M	(26.7M)	(55.4M)	(52.6M)
Retained Earnings	(138.0M)	(166.0M)	(168.8M)	(160.0M)	(211.8M)	(201.2M)
Cash	94.6M	79.2M	41.9M	38.4M	64.0M	39.0M
Non Current Assets Total	219.5M	210.2M	205.3M	14.9M	11.9M	11.3M
Non Currrent Assets Other	27.2M	29.6M	36.1M	1.6M	1.9M	1.8M
Cash And Short Term Investments	94.6M	79.2M	41.9M	38.4M	64.0M	43.3M
Net Receivables	63.3M	61.5M	82.9M	442K	108K	102.6K
Common Stock Shares Outstanding	34.4M	35.3M	36.1M	37.0M	19.5M	23.3M
Liabilities And Stockholders Equity	433.8M	391.6M	380.1M	54.9M	78.3M	74.4M
Non Current Liabilities Total	231.5M	225.7M	259.3M	170.9M	5.6M	5.3M
Inventory	36.8M	23.7M	18.3M	23.9M	27.5M	15.1M
Other Current Assets	24.8M	22.3M	26.0M	1.2M	2.2M	2.1M
Other Stockholder Equity	233.7M	242.4M	184.7M	36.2M	274.9M	288.6M
Total Liab	338.7M	316.2M	365.8M	178.7M	15.2M	14.4M
Total Current Assets	214.3M	181.4M	174.8M	40.0M	66.4M	92.1M
Accumulated Other Comprehensive Income	(661K)	(1.4M)	(985K)	(1.4M)	(1.9M)	0.0
Short Term Debt	4.3M	2.6M	705K	3.5M	3.1M	4.5M
Accounts Payable	35.8M	31.8M	52.7M	1.0M	1.2M	1.1M
Common Stock	352K	361K	374K	1K	2K	1.9K
Good Will	106.3M	94.6M	94.4M	94.2M	108.3M	58.0M
Intangible Assets	45.9M	37.5M	32.0M	26.6M	30.6M	31.6M
Current Deferred Revenue	32.9M	26.2M	25.4M	385K	442.8K	420.6K

Pair Trading with CAMP4 THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

Moving together with CAMP4 Stock

0.8

ERNA

Eterna Therapeutics

Pair Corr

Moving against CAMP4 Stock

0.77	CICHF	China Construction Bank	Pair Corr
0.76	PFE	Pfizer Inc Earnings Call This Week	Pair Corr
0.66	A	Agilent Technologies Earnings Call Tomorrow	Pair Corr
0.65	PTHL	Pheton Holdings	Pair Corr
0.63	BNTX	BioNTech SE Earnings Call Tomorrow	Pair Corr

The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.

The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC